Review Explores AI for Early Detection of Interval Breast Cancers

AI tools may detect or predict interval breast cancers earlier, potentially lowering missed cancers in screening mammography and improving program effectiveness, according to a new review.

• Interval cancers diagnosed between screenings carry a worse prognosis, making their reduction a key metric of screening success.
• Artificial intelligence models are emerging with potential for earlier detection or even prediction of these cancers.
• The review covers current evidence and considerations for interpreting AI findings in this context.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.